Рет қаралды 1,944
Neuropathic pain is very common but finding efficacious and well tolerated treatment regimens can be a challenge. James Watson, M.D., a neurologist at Mayo Clinic discusses how neuropathic pain adjuvants that are non-opioid based are underutilized. He shares tips for non-opioid pharmacologic management of neuropathic pain, how to optimize first line drug options, and secondary options for refractory cases.
00:00 Introduction
1:07 FDA approved medications
4:41 Tricyclic antidepressants, duloxetine, venlafaxine, and gabapentinoid agents
17:00 Lack of efficacy in first line agents
20:39 Managing expectations
23:35 Adding medications
25:52 Topical and injectable treatments
30:01 Naturopathic agents, sodium channel blockers, and compounded creams
33:32 NMDA antagonists, naltrexone, and cannabinoids
Interested in CME? Conveniently earn unlimited AMA PRA Category 1 Credit(s)™ by subscribing to GIBLIB’s premium plan.
GIBLIB is increasing access to credible medical updates and the highest quality medical education by partnering with the best in medicine, such as Mayo Clinic, University of California San Francisco, Cleveland Clinic, Cedars-Sinai Medical Center, Hospital for Special Surgery, Stanford Children’s Hospital and more.
Learn more about GIBLIB at hubs.la/Q014B2W60
Visit our blog at hubs.la/Q014B2Wg0
⟡ Follow Us ⟡
Instagram: / giblib
Facebook: / thegiblibapp
Twitter: / thegiblibapp
LinkedIn: / giblib
#PrimaryCare #MayoClinic #Opioid